Standard
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. / Khademi, Mohsen; Kockum, Ingrid; Andersson, Magnus L; Iacobaeus, Ellen; Brundin, Lou; Sellebjerg, Finn; Hillert, Jan; Piehl, Fredrik; Olsson, Tomas.
I:
Multiple Sclerosis, Bind 17, Nr. 3, 2011, s. 335-43.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Khademi, M, Kockum, I, Andersson, ML, Iacobaeus, E, Brundin, L
, Sellebjerg, F, Hillert, J, Piehl, F & Olsson, T 2011, '
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course',
Multiple Sclerosis, bind 17, nr. 3, s. 335-43.
https://doi.org/10.1177/1352458510389102APA
Khademi, M., Kockum, I., Andersson, M. L., Iacobaeus, E., Brundin, L.
, Sellebjerg, F., Hillert, J., Piehl, F., & Olsson, T. (2011).
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
Multiple Sclerosis,
17(3), 335-43.
https://doi.org/10.1177/1352458510389102Vancouver
Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L
, Sellebjerg F o.a.
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
Multiple Sclerosis. 2011;17(3):335-43.
https://doi.org/10.1177/1352458510389102Author
Khademi, Mohsen ; Kockum, Ingrid ; Andersson, Magnus L ; Iacobaeus, Ellen ; Brundin, Lou ; Sellebjerg, Finn ; Hillert, Jan ; Piehl, Fredrik ; Olsson, Tomas. / Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. I: Multiple Sclerosis. 2011 ; Bind 17, Nr. 3. s. 335-43.
Bibtex
@article{3efbfbd2dd924e19936b673e4247728a,
title = "Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course",
abstract = "Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.",
author = "Mohsen Khademi and Ingrid Kockum and Andersson, {Magnus L} and Ellen Iacobaeus and Lou Brundin and Finn Sellebjerg and Jan Hillert and Fredrik Piehl and Tomas Olsson",
year = "2011",
doi = "http://dx.doi.org/10.1177/1352458510389102",
language = "English",
volume = "17",
pages = "335--43",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "3",
}
RIS
TY - JOUR
T1 - Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
AU - Khademi, Mohsen
AU - Kockum, Ingrid
AU - Andersson, Magnus L
AU - Iacobaeus, Ellen
AU - Brundin, Lou
AU - Sellebjerg, Finn
AU - Hillert, Jan
AU - Piehl, Fredrik
AU - Olsson, Tomas
PY - 2011
Y1 - 2011
N2 - Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.
AB - Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.
U2 - http://dx.doi.org/10.1177/1352458510389102
DO - http://dx.doi.org/10.1177/1352458510389102
M3 - Journal article
VL - 17
SP - 335
EP - 343
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
SN - 1352-4585
IS - 3
ER -
